Immunomodulation of nicotine in HIV-1Tg rat brain

尼古丁对 HIV-1Tg 大鼠脑的免疫调节作用

基本信息

  • 批准号:
    10378566
  • 负责人:
  • 金额:
    $ 34.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-05-01 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

Project Summary: As one of the key active ingredients of tobacco smoke, nicotine exerts its actions primarily on the nicotinic acetylcholine receptors (nAChRs), which are expressed on neurons, microglia, and other cells in the central nervous system (CNS). Activation of nAChRs by nicotine has various potential therapeutic immune benefits, including modulation of inflammatory responses, maintenance of immune homeostasis, and regulation of expression of pro- and anti-inflammatory factors. However, smokers have a higher rate of HIV disease progression and behavioral and cognitive complications, with differences seen between male and female smokers. It has been suggested that prolonged exposure to nicotine in HIV patients through cigarette smoking might decrease the expression and desensitize the activation of nAChRs, which could dampen nicotine's ability to mediate immune responses. During the past several years, we have conducted a series of behavioral and molecular studies using a rodent HIV-1 transgenic (HIV-1Tg) rat model to study various medical issues, including immunity, associated with HIV patients receiving combined anti-retroviral therapy (cART). We used this HIV-transgenic rat model to determine the effects of nicotine on brain function in the presence of HIV-1 proteins and found that chronic treatment with nicotine can restore the expression of many genes altered by the HIV-1 viral proteins in signaling pathways involved in immunity and other neuronal systems. In addition, we found that expression of various nAChR subunits, especially α6, β3, and β4, and immune-related genes, such as interferon regulatory factor 7 (IRF7) and interleukin-1α (IL-1α), differ greatly in HIV-1Tg rats compared with F344 controls. Our findings indicate that HIV-1 proteins greatly impact CNS immunity as well as nAChR function and alter the responsiveness to nicotine in certain immune-related and nAChR-mediated signaling pathways. Based on these findings, we hypothesize that there are significant interactions between nicotine and HIV-1 proteins that affect the immune response to nicotine in the brain of HIV-1-positive individuals. To test this hypothesis, we propose the following three aims. Aim 1 is to determine the interactive effects of nicotine and HIV viral proteins on microglia and macrophages in the brain as well as cytokine production in the blood and brain of the HIV-1Tg rat. Aim 2 is to compare the interactive effects of nicotine and HIV-1 viral proteins on gene expression in three brain regions of male and female HIV-1Tg rats using RNA-seq analysis. Aim 3 is to characterize specific genes and pathways that mediate the effects of the interaction between nicotine and HIV- 1 viral proteins using various molecular techniques, including CRISPR gene editing. The proposed studies represent the first application of next-generation sequencing technique in combination with conventional molecular approaches to investigate the modulatory effects of chronic use of nicotine on CNS immunity in the presence of HIV-1 viral proteins. By combining both genomic and molecular approaches, our studies will be comprehensive and free of subjective bias and assure the value of the data for the development of new strategies for treating HIV-1 patients who use nicotine.
项目总结:

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Bi-directional Acceleration of Alcohol Use and Opioid Use Disorder.
酒精使用和阿片类药物使用障碍的双向加速。
  • DOI:
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Huang,Wenfei;Penaherrera,ErikaP;Desir,DanaikaF;Gamarro,DominickL;Cottrell,Jessica;Chu,Tinchun;Chang,SulieL
  • 通讯作者:
    Chang,SulieL
Meta-Analysis of APP Expression Modulated by SARS-CoV-2 Infection via the ACE2 Receptor.
The Neuroimmune Pharmacology of SARS-CoV-2.
Meta-Analysis of the Mechanisms Underlying COVID-19 Modulation of Parkinson's Disease.
Kinases: Understanding Their Role in HIV Infection.
  • DOI:
    10.4236/wja.2019.93011
  • 发表时间:
    2019-09-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    De Martini, William;Rahman, Roksana;Chang, Sulie L
  • 通讯作者:
    Chang, Sulie L
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SULIE L. CHANG其他文献

SULIE L. CHANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SULIE L. CHANG', 18)}}的其他基金

Effects of binge ethanol on neuroinflammation and neurodegeneration with high fat diets
暴饮乙醇对高脂肪饮食引起的神经炎症和神经变性的影响
  • 批准号:
    10668068
  • 财政年份:
    2023
  • 资助金额:
    $ 34.78万
  • 项目类别:
Involvement of microglial α7AChR in binge alcohol modulation of gut dysbiosis
小胶质细胞α7AChR参与酗酒调节肠道菌群失调
  • 批准号:
    10705750
  • 财政年份:
    2022
  • 资助金额:
    $ 34.78万
  • 项目类别:
Involvement of microglial α7AChR in binge alcohol modulation of gut dysbiosis
小胶质细胞α7AChR参与酗酒调节肠道菌群失调
  • 批准号:
    10527744
  • 财政年份:
    2022
  • 资助金额:
    $ 34.78万
  • 项目类别:
Modulation of OPRM1 alternative splicing by morphine and HIV-1 Nef
吗啡和 HIV-1 Nef 对 OPRM1 选择性剪接的调节
  • 批准号:
    10654016
  • 财政年份:
    2021
  • 资助金额:
    $ 34.78万
  • 项目类别:
Methylation in binge ethanol-induced spleen atrophy in adolescent rats
青春期大鼠暴食乙醇引起的脾萎缩的甲基化
  • 批准号:
    10400702
  • 财政年份:
    2018
  • 资助金额:
    $ 34.78万
  • 项目类别:
Immunomodulation of nicotine in HIV-1Tg rat brain
尼古丁对 HIV-1Tg 大鼠脑的免疫调节作用
  • 批准号:
    9897503
  • 财政年份:
    2018
  • 资助金额:
    $ 34.78万
  • 项目类别:
Methylation in binge ethanol-induced spleen atrophy in adolescent rats
青春期大鼠暴食乙醇引起的脾萎缩的甲基化
  • 批准号:
    10155374
  • 财政年份:
    2018
  • 资助金额:
    $ 34.78万
  • 项目类别:
Alcohol-induced Impairment of Endothelial Cell Recovery
酒精引起的内皮细胞恢复损伤
  • 批准号:
    9238541
  • 财政年份:
    2017
  • 资助金额:
    $ 34.78万
  • 项目类别:
Involvement of TRP Channels in Ethanol Concentration-Dependent Effects on Immune
TRP 通道参与乙醇浓度依赖性免疫效应
  • 批准号:
    8740695
  • 财政年份:
    2014
  • 资助金额:
    $ 34.78万
  • 项目类别:
Involvement of TRP Channels in Ethanol Concentration-Dependent Effects on Immune
TRP 通道参与乙醇浓度依赖性免疫效应
  • 批准号:
    8936414
  • 财政年份:
    2014
  • 资助金额:
    $ 34.78万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 34.78万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 34.78万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 34.78万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 34.78万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 34.78万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 34.78万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 34.78万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 34.78万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 34.78万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 34.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了